[The coming diabetes tsunami: the Netherlands should exploit its lead]
1Academisch Medisch Centrum/Universiteit van Amsterdam, afd. Huisartsgeneeskunde, Amsterdam, The Netherlands. g.terriet@amc.uva.nl
Nederlands Tijdschrift Voor Geneeskunde
|September 30, 2009
Summary
The projected 1.32 million diabetes mellitus cases in the Netherlands by 2025 may be overestimated. This commentary questions assumptions about age, early detection, and sustained overweight rates, suggesting modifiable factors and interventions are key.
Area of Science:
- Epidemiology
- Public Health
- Gerontology
Context:
- A previous projection estimated 1.32 million diabetes mellitus diagnoses in the Netherlands by 2025, assuming current trends continue.
- This commentary critically examines the assumptions underpinning this projection, particularly concerning age, detection rates, and overweight trends.
Purpose:
- To challenge the immutable link between advanced age and diabetes, highlighting the potential for modifiable underlying mechanisms.
- To re-evaluate the impact of improved early diabetes detection on prevalence rates and identify opportunities for intervention.
- To question the assumption of sustained current overweight rates until 2025.
Summary:
- The author argues that advanced age is not an immutable cause of diabetes and that improved early detection offers avenues for intervention.
- The commentary disputes the likelihood of current overweight trends persisting until 2025.
- It also touches upon the debate surrounding the U.S. Diabetes Prevention Program, its cost-effectiveness modeling (Archimedes vs. Markov models), and treatment with metformin.
Impact:
- Provides a critical perspective on diabetes prevalence projections, emphasizing the role of modifiable factors.
- Highlights the importance of considering dynamic trends in overweight and early detection in public health planning.
- Contributes to the ongoing discussion on diabetes prevention strategies and epidemiological modeling validation.
Related Concept Videos
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...